Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
2 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
3 | Coronavirus disease - COVID-19 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
4 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
5 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
6 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
7 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
8 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
9 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
10 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
11 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
12 | Hematopoietic cell lineage 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
13 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
14 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
15 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
16 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
17 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
18 | Human cytomegalovirus infection 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
19 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
20 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
21 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
22 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
23 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
24 | Non-alcoholic fatty liver disease 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
25 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
26 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
27 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
28 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
29 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
30 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
31 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
32 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
33 | Th17 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|
34 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Sarilumab Sarilumab 💬
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬
|
35 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Satralizumab Satralizumab 💬
| Satralizumab | 011 [3] 11, 13, 86 💬
|
36 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 3 drugs (DrugBank) and 22 diseases |
IL6R [1] IL6R 💬
|
Tocilizumab Tocilizumab 💬
| Tocilizumab | 002 [21] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
|